These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33767597)

  • 41. Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2.
    Cui Y; Chen F; Gao J; Lei M; Wang D; Jin X; Guo Y; Shan L; Chen X
    Int J Biol Sci; 2021; 17(14):3795-3817. PubMed ID: 34671200
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients.
    Ren P; Gong C; Ma S
    Open Med (Wars); 2020; 15(1):613-622. PubMed ID: 33336018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is There any Alternative Receptor for SARS-CoV-2?
    Shahriari Felordi M; Memarnejadian A; Najimi M; Vosough M
    Cell J; 2021 Jul; 23(2):247-250. PubMed ID: 34096226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference.
    Wang Q; Shu R; He H; Wang L; Ma Y; Zhu H; Wang Z; Wang S; Shen G; Lei P
    Int J Oncol; 2012 Aug; 41(2):652-60. PubMed ID: 22581315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
    Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
    Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.
    Rayner JO; Roberts RA; Kim J; Poklepovic A; Roberts JL; Booth L; Dent P
    Biochem Pharmacol; 2020 Dec; 182():114227. PubMed ID: 32966814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
    Lange C; Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Lapp T; Horres R; Agostini H; Martin G; Reinhard T; Schlunck G
    J Med Virol; 2020 Oct; 92(10):2081-2086. PubMed ID: 32374427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage.
    Ha DP; Shin WJ; Hernandez JC; Neamati N; Dubeau L; Machida K; Lee AS
    Viruses; 2023 May; 15(5):. PubMed ID: 37243204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 Induces Epithelial-Enteric Neuronal Crosstalk Stimulating VIP Release.
    Balasubramaniam A; Tedbury PR; Mwangi SM; Liu Y; Li G; Merlin D; Gracz AD; He P; Sarafianos SG; Srinivasan S
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 and Cell Stress.
    Elfiky AA; Ibrahim IM; Amin FG; Ismail AM; Elshemey WM
    Adv Exp Med Biol; 2021; 1318():169-178. PubMed ID: 33973178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of Patients With Glucocorticoid-Related Diseases and COVID-19.
    Chifu I; Detomas M; Dischinger U; Kimpel O; Megerle F; Hahner S; Fassnacht M; Altieri B
    Front Endocrinol (Lausanne); 2021; 12():705214. PubMed ID: 34594302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene expression and
    Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
    Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
    Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of aging on deterioration of patients with COVID-19.
    Pang L; Liu Y; Shen M; Ye J; Chen R; Lan Z; Wu Z; Guo Y; Zhang P
    Aging (Albany NY); 2020 Nov; 12(24):26248-26262. PubMed ID: 33232272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
    Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
    Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular HSPA5 is autocrinally involved in the regulation of neuronal process elongation.
    Fukawa M; Shirai R; Torii T; Nakata K; Fukatsu S; Sato T; Homma K; Miyamoto Y; Yamauchi J
    Biochem Biophys Res Commun; 2023 Jul; 664():50-58. PubMed ID: 37137223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of allosteric signaling in DnaK and BiP using mutual information between simulated residue conformations.
    Schneider M; Antes I
    Proteins; 2023 Feb; 91(2):237-255. PubMed ID: 36111439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
    Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
    Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.